NDC 79929-002 - Levonorgestrel and Ethinyl Estradiol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79929-002
- Manufacturer
- Naari Pte Limited | Naari Pharma Private Limited
- Effective date
- 2024-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEVONORGESTREL - Naari Pte Limited | Naari Pharma Private Limited | Naari Pte Limited | Naari Pharma Private Limited | 2024-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levonorgestrel | LEVONORGESTREL | Xiromed LLC | 626a2333-ff56-ef28-a287-b33bacc0302a | 2023-09-05 | Warnings | 5W7SIA7YZW |
| DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 142c4b90-c9ab-45ce-9172-f1ea7d366686 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Xiromed, LLC. | 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Syeda | DROSPIRENONE AND ETHINYL ESTRADIOL | Xiromed, LLC. | e1586633-1973-c396-6f4a-4c55cce4b59e | 2023-07-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Alumina | ALUMINUM OXIDE | Boiron | 84b4fd05-f2cc-3b45-e053-2991aa0ad5d9 | 2023-07-11 | LMI26O6933 | |
| LORYNA | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | Xiromed, LLC. | da872266-d5f2-35df-096e-341f58d93427 | 2023-07-10 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Alumina | ALUMINA | Hahnemann Laboratories, INC. | ffdbdb70-8666-f0c6-e053-6394a90a6596 | 2023-07-06 | LMI26O6933 | |
| LILETTA | LEVONORGESTREL | Allergan, Inc. | aaf0eb2a-f88a-4f26-a445-0fd30176c326 | 2023-06-29 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Alumina | ALUMINUM OXIDE | Boiron | a9603cb0-7c3b-11e6-8197-424c58303031 | 2023-06-26 | LMI26O6933 | |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 5c1d0a3a-1b24-44a0-9c53-224365b65945 | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | 238019 |
| Yasmin | DROSPIRENONE AND ETHINYL ESTRADIOL | Bayer HealthCare Pharmaceuticals Inc. | d7ea6a60-5a56-4f81-b206-9b27b7e58875 | 2023-05-19 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Nextstellis | DROSPIRENONE AND ESTETROL | Mayne Pharma | c5270073-d083-4109-ae4b-156986175e0a | 2023-05-11 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Tri-VyLibra Lo | NORGESTIMATE AND ETHINYL ESTRADIOL | Afaxys Pharma, LLC | bd51a08e-cd45-4315-9bca-41794450ef16 | 2023-05-04 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | Proficient Rx LP | 9c4fac8e-8744-4378-80af-7887de955a51 | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Alumina | ALUMINUM OXIDE | Boiron | 8426bd35-372c-4417-e053-2a91aa0a7903 | 2023-04-11 | LMI26O6933 | |
| Levonorgetsrel and Ethinyl Estradiol | LEVONORGETSREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | b04e1404-6eee-48f3-a51e-66de3fc95b60 | 2023-04-01 | Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Alumina | ALUMINUM OXIDE | Boiron | 84274737-2fed-d542-e053-2a91aa0a1ead | 2023-03-28 | LMI26O6933 | |
| Alumina | ALUMINUM OXIDE | Boiron | 84270ebe-2cd9-7fb5-e053-2a91aa0ab7d5 | 2023-03-27 | LMI26O6933 | |
| Levonorgestrel | LEVONORGESTREL | Naari Pte Limited | be8b7ace-9af8-4417-85fa-863e19072887 | 2023-03-16 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.